Inventor · disambiguated record
Simon Goodman
Also filed as: GOODMAN SIMON · GOODMAN SIMON L · GOODMAN SIMON LAWRENCE
27 granted patents·20 pending applications·435 citations·filing 1995–2013
96Inventor score
Top patents by PatentIndex Score
47 records- 0192US6559144B2Bicyclic amino acidsMERCK PATENT GMBH·Filed 2001·Granted May 6, 2003·52 cites·12 claims
- 0289US8562986B2Engineered anti-alpha V-integrin hybrid antibodiesGOODMAN SIMON·Filed 2008·Granted Oct 22, 2013·26 cites·36 claims
- 0388US6001961ACyclic adhesion inhibitorsMERCK PATENT GMBH·Filed 1996·Granted Dec 14, 1999·88 cites·5 claims
- 0484US5985278AAnti-αV-integrin monoclonal antibodyMERCK PATENT GMBH·Filed 1995·Granted Nov 16, 1999·86 cites·23 claims
- 0582US7138417B2Inhibitors of integrin αvβ6MERCK PATENT GMBH·Filed 2003·Granted Nov 21, 2006·17 cites·20 claims
- 0679US6326403B1Diacylhydrazine derivatives as integrin inhibitorsMERCK PATENT GMBH·Filed 1999·Granted Dec 4, 2001·49 cites·19 claims
- 0777US8420348B2Antibodies for the detection of integrin complexes in FFPE materialGOODMAN SIMON·Filed 2010·Granted Apr 16, 2013·3 cites·5 claims
- 0876US6649613B1Diacylhydrazine derivativesMERCK PATENT GMBH·Filed 2000·Granted Nov 18, 2003·11 cites·35 claims
- 0972US6743810B2Indol-3-yl derivativesMERCK PATENT GMBH·Filed 2001·Granted Jun 1, 2004·6 cites·19 claims
- 1071US8993261B2Antibodies for the detection of integrin complexes in FFPE materialMERCK PATENT GMBH·Filed 2013·Granted Mar 31, 2015·1 cites·21 claims
- 1171US6645991B1αvβ3 integrin inhibitorsMERCK PATENT GMBH·Filed 2000·Granted Nov 11, 2003·5 cites·16 claims
- 1270US7029652B2Method of treating tumorsMERCK PATENT GMBH·Filed 2002·Granted Apr 18, 2006·5 cites·33 claims
- 1370US5693612ACyclopeptides of the formula IMERCK PATENT GMBH·Filed 1995·Granted Dec 2, 1997·32 cites·9 claims
- 1469US6521646B1Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosisMERCK PATENT GMBH·Filed 2000·Granted Feb 18, 2003·4 cites·21 claims
- 1564US2009035270A1COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alphaGRELL MATTHIAS·Filed 2007·Application pending·0 cites
- 1662US7632951B2Inhibitors of integrin ανβ6MERCK PATENT GMBH·Filed 2002·Granted Dec 15, 2009·1 cites·26 claims
- 1762US6127335ACyclic adhesion inhibitorsMERCK PATENT GMBH·Filed 1997·Granted Oct 3, 2000·18 cites·5 claims
- 1859US7060707B2Isoquinoline derivativesMERCK PATENT GMBH·Filed 2003·Granted Jun 13, 2006·1 cites·16 claims
- 1958US2010190957A1Specific therapy and medicament using integrin ligands for treating cancerKRUEGER STEFAN·Filed 2008·Application pending·0 cites
- 2054US6683051B1Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitorMERCK PATENT GMBH·Filed 1999·Granted Jan 27, 2004·15 cites·14 claims
- 2154US2009130098A1Specific therapy using integrin ligands for treating cancerMERCK PATENT GMBH·Filed 2007·Application pending·0 cites
- 2254US2011177027A1COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalphaGRELL MATTHIAS·Filed 2011·Application pending·0 cites
- 2353US2004136949A1Combination therapy using anti-angiogenic agents and tnf alphaGRELL MATTHIAS·Filed 2002·Application pending·0 cites
- 2451US2010069302A1Specific therapy and medicament using integrin ligands for treating cancerKRUEGER STEFAN·Filed 2008·Application pending·0 cites
- 2549US2006153770A1Method of treating tumorsMERCK PATENT GMBH·Filed 2006·Application pending·0 cites
- 2648US6534478B1Cyclic azapeptides with angiogenic effectMERCK PATENT GMBH·Filed 1998·Granted Mar 18, 2003·8 cites·8 claims
- 2748US2006142548A1Methods of identifying and designing cell surface receptor inhibitorsARNAOUT M A·Filed 2005·Application pending·0 cites
- 2845US8067197B2Soluble recombinant αvβ3 adhesion receptorGOODMAN SIMON L·Filed 2003·Granted Nov 29, 2011·0 cites·6 claims
- 2944US2007117849A1Alfavbeta3 and alfavbet6 integrin antagonists as antifibrotic agentsGOODMAN SIMON·Filed 2004·Application pending·0 cites
- 3043US10478501B2Method of treating disorders using a pharmaceutical composition of oligopeptidesGOODMAN SIMON·Filed 2012·Granted Nov 19, 2019·0 cites·25 claims
- 3143US2004138284A1Indol-3-yl derivativesWIESNER MATTHIAS·Filed 2004·Application pending·0 cites
- 3242US2011165150A1Isolated organ perfusion combination therapy of cancerMERCK PATENT GMBH·Filed 2006·Application pending·0 cites
- 3341US7135587B2Urea and urethane derivatives as integrin inhibitorsMERCK PATENT GMBH·Filed 2001·Granted Nov 14, 2006·0 cites·18 claims
- 3441US2004052785A1Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitorsFiled 2001·Application pending·0 cites
- 3541US2004142877A1Ligands of the $g(a)v$g(b)6 integrinFiled 2002·Application pending·0 cites
- 3640US6333308B1Cyclic peptide derivativesMERCK KGAA·Filed 1997·Granted Dec 25, 2001·4 cites·31 claims
- 3740US2004157902A1Integrin antagonistsFiled 2002·Application pending·0 cites
- 3839US2011223167A1Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitorsGOODMAN SIMON·Filed 2010·Application pending·0 cites
- 3938US7125699B2Identification of a human N-terminal acetyltransferase geneMERCK PATENT GMBH·Filed 2001·Granted Oct 24, 2006·0 cites·8 claims
- 4038US2013289259A1Aptamer labelled with f-19 nucleus for targeted molecular imaging by mriGUENTHER RALF·Filed 2011·Application pending·0 cites
- 4137US2004010023A1Biphenyl derivatives and the use thereof as integrin inhibitorsFiled 2001·Application pending·0 cites
- 4236US6566491B2Cyclopeptide derivativesMERCK PATENT GMBH·Filed 1996·Granted May 20, 2003·3 cites·10 claims
- 4335US2003187289A1Biphenyl derivatives and the use thereof as integrin inhibitorsFiled 2001·Application pending·0 cites
- 4434US2004091895A1Human sprouty-4 polypeptideFiled 2001·Application pending·0 cites
- 4533US7037699B2Human extracellular signal regulated kinasesMERCK PATENT GMBH·Filed 2001·Granted May 2, 2006·0 cites·7 claims
- 4628US6849646B1Chromenone and chromanone derivatives as integrin inhibitorsMERCK PATENT GMBH·Filed 1999·Granted Feb 1, 2005·0 cites·24 claims
- 4724US2002055136A1Soluble recombinant alpha beta adhesion receptorFiled 1997·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →